ArticleCancer medicine2026

Serial ctDNA Analysis for Monitoring Molecular Response and Acquired Resistance in Metastatic NSCLC and HR+/HER2-Negative Breast Cancer: A Real-World Study.

Franciele Hinterholz Knebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.